Full Text View
Tabular View
No Study Results Posted
Related Studies
Prolonged Exposure (PE) Treatment for Post Traumatic Stress Disorder (PTSD) 20 Minutes Versus 40 Minutes
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2010 by Sheba Medical Center.
Recruitment status was  Recruiting
Study NCT00229307   Information provided by Sheba Medical Center

First Received on September 28, 2005.   Last Updated on February 7, 2010   History of Changes

September 28, 2005
February 7, 2010
December 2005
December 2010   (final data collection date for primary outcome measure)
PSS-i [ Time Frame: 15 weeks and 1-year follow-up ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00229307 on ClinicalTrials.gov Archive Site
 
 
 
 
 
Prolonged Exposure (PE) Treatment for Post Traumatic Stress Disorder (PTSD) 20 Minutes Versus 40 Minutes
 

Comparing the efficacy of 40 minutes PE treatment to 20 minutes of the same treatment

 
Interventional
 
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
PTSD
  • Behavioral: Prolonged Exposure (PE) therapy
    20 minutes exposure
  • Behavioral: Prolonged Exposure (PE) therapy
    40 minutes exposure
  • Active Comparator: 1
    Intervention: Behavioral: Prolonged Exposure (PE) therapy
  • Active Comparator: 2
    Intervention: Behavioral: Prolonged Exposure (PE) therapy
 

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
20
December 2010
December 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • PTSD

Exclusion Criteria:

  • Psychotic symptoms
  • Dissociation
  • Drug or Alcohol dependence
Both
18 Years to 65 Years
No
Contact: Leah Fostick, MA +972-3-5357805 Leah.Fostick@sheba.health.gov.il
Israel
 
NCT00229307
SHEBA-05-3709-JZ-CTIL
No
Prof. Joseph Zohar, Chaim Sheba Medical Center
Sheba Medical Center
 
Study Chair: Nitza Nacasch, MD Tel Aviv University
Principal Investigator: Joseph Zohar, MD Tel Aviv University
Sheba Medical Center
February 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP